Review
Myelodysplastic syndromes: natural history and features of prognostic importance
- PMID: 3552350
Item in Clipboard
Review
Myelodysplastic syndromes: natural history and features of prognostic importance
Clin Haematol.
1986 Nov.
No abstract available
Similar articles
-
The myelodysplastic syndromes. Part I. What are they? Part II. Classification.Scand J Haematol Suppl. 1986;45:11-20. Scand J Haematol Suppl. 1986. PMID: 3515515 Review. No abstract available.
-
Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.Leuk Res. 2008 Jan;32(1):33-7. doi: 10.1016/j.leukres.2007.02.021. Epub 2007 Apr 6. Leuk Res. 2008. PMID: 17412418
-
[The myelodysplastic syndrome based on our cases].Orv Hetil. 1986 Aug 17;127(33):1993-8. Orv Hetil. 1986. PMID: 3466134 Hungarian. No abstract available.
-
Classification of the myelodysplastic syndromes.Clin Haematol. 1986 Nov;15(4):909-23. Clin Haematol. 1986. PMID: 3471370 No abstract available.
-
Chromosome abnormalities in the myelodysplastic syndromes.Clin Haematol. 1986 Nov;15(4):1003-21. Clin Haematol. 1986. PMID: 3552345 Review. No abstract available.
Cited by
-
Analysis of bone marrow and peripheral blood immunoregulatory lymphocytes in patients with myelodysplastic syndrome.Ann Hematol. 1995 Dec;71(6):293-9. doi: 10.1007/BF01697982. Ann Hematol. 1995. PMID: 8534761
-
Identification and treatment of anaemia in older patients.Drugs Aging. 1994 Feb;4(2):113-27. doi: 10.2165/00002512-199404020-00004. Drugs Aging. 1994. PMID: 8186539 Review.
-
Phase 1-2a multicenter dose-escalation study of ezatiostat hydrochloride liposomes for injection (Telintra, TLK199), a novel glutathione analog prodrug in patients with myelodysplastic syndrome.J Hematol Oncol. 2009 May 13;2:20. doi: 10.1186/1756-8722-2-20. J Hematol Oncol. 2009. PMID: 19439093 Free PMC article. Clinical Trial.
-
Transformation of myelodysplastic syndrome to acute lymphoblastic leukemia: a case report and review of the literature.Int J Hematol. 2004 Feb;79(2):147-51. doi: 10.1532/ijh97.03137. Int J Hematol. 2004. PMID: 15005342 Review.
-
Recombinant Granulocyte-Macrophage Colony-Stimulating Factor (rGM-CSF) : A Review of its Pharmacological Properties and Prospective Role in the Management of Myelosuppression.Drugs. 1992 Apr;43(4):516-560. doi: 10.2165/00003495-199243040-00008. Drugs. 1992. PMID: 28421558
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical